Antigen-Dependent Integration of Opposing Proximal TCR-Signaling Cascades Determines the Functional Fate of T Lymphocytes
暂无分享,去创建一个
G. Nolan | S. Shen-Orr | Y. Reiter | K. Oved | R. Wolchinsky | S. Bendall | Moran Hod-Marco | Shen-Orr S. Shai
[1] D. Speiser,et al. SHP-1 phosphatase activity counteracts increased T cell receptor affinity. , 2013, The Journal of clinical investigation.
[2] U. Sivan,et al. Mixed alkanethiol monolayers on submicrometric gold patterns: a controlled platform for studying cell-ligand interactions. , 2012, Nano letters.
[3] Sean C. Bendall,et al. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. , 2012, Immunity.
[4] E. Wherry. T cell exhaustion , 2011, Nature Immunology.
[5] Sean C. Bendall,et al. Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum , 2011, Science.
[6] J. Groves,et al. T-cell triggering thresholds are modulated by the number of antigen within individual T-cell receptor clusters , 2011, Proceedings of the National Academy of Sciences.
[7] Albert J R Heck,et al. High-resolution mapping of prostaglandin E2-dependent signaling networks identifies a constitutively active PKA signaling node in CD8+CD45RO+ T cells. , 2010, Blood.
[8] K. Ravichandran,et al. A Key Role for the Phosphorylation of Ser440 by the Cyclic AMP-dependent Protein Kinase in Regulating the Activity of the Src Homology 2 Domain-containing Inositol 5′-Phosphatase (SHIP1)* , 2010, The Journal of Biological Chemistry.
[9] Omer Dushek,et al. Constitutively Active Lck Kinase in T Cells Drives Antigen Receptor Signal Transduction , 2010, Immunity.
[10] Ash A. Alizadeh,et al. B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression , 2010, Proceedings of the National Academy of Sciences.
[11] E. Borden,et al. Novel SHP-1 Inhibitors Tyrosine Phosphatase Inhibitor-1 and Analogs with Preclinical Anti-Tumor Activities as Tolerated Oral Agents , 2010, The Journal of Immunology.
[12] Boris N. Kholodenko,et al. Signalling ballet in space and time , 2010, Nature Reviews Molecular Cell Biology.
[13] S. Jameson,et al. Diversity in T cell memory: an embarrassment of riches. , 2009, Immunity.
[14] S. Rosenberg,et al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. , 2009, Blood.
[15] P. Romero,et al. Expression Hierarchy of T Cell Epitopes from Melanoma Differentiation Antigens: Unexpected High Level Presentation of Tyrosinase-HLA-A2 Complexes Revealed by Peptide-Specific, MHC-Restricted, TCR-Like Antibodies1 , 2009, The Journal of Immunology.
[16] G. Koretzky,et al. T cell activation. , 2009, Annual review of immunology.
[17] E. Klechevsky,et al. Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts. , 2008, Cancer research.
[18] G. Freeman,et al. PD-1 and its ligands in tolerance and immunity. , 2008, Annual review of immunology.
[19] Lieping Chen,et al. Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy. , 2007, Blood.
[20] Mark M Davis,et al. T cells as a self-referential, sensory organ. , 2007, Annual review of immunology.
[21] M. Bevan,et al. Effector and memory CTL differentiation. , 2007, Annual review of immunology.
[22] N. Amariglio,et al. A Novel Postpriming Regulatory Check Point of Effector/Memory T Cells Dictated through Antigen Density Threshold-Dependent Anergy , 2007, The Journal of Immunology.
[23] Barbara Hausmann,et al. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling , 2006, Nature.
[24] Philip J. R. Goulder,et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.
[25] Rajat Varma,et al. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. , 2006, Immunity.
[26] R. Schwartz,et al. Adaptive Tolerance and Clonal Anergy Are Distinct Biochemical States1 , 2006, The Journal of Immunology.
[27] Takashi Saito,et al. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76 , 2005, Nature Immunology.
[28] S. Rosenberg,et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] U. Lorenz,et al. Localization of Src Homology 2 Domain-Containing Phosphatase 1 (SHP-1) to Lipid Rafts in T Lymphocytes: Functional Implications and a Role for the SHP-1 Carboxyl Terminus1 , 2005, The Journal of Immunology.
[30] Timothy K Starr,et al. Positive and negative selection of T cells. , 2003, Annual review of immunology.
[31] Mark M. Davis,et al. Linker for Activation of T Cells, ζ-Associated Protein-70, and Src Homology 2 Domain-Containing Leukocyte Protein-76 are Required for TCR-Induced Microtubule-Organizing Center Polarization1 , 2003, The Journal of Immunology.
[32] B. Freedman,et al. Regulation of T Cell Activation and Tolerance by Phospholipase Cγ-1-Dependent Integrin Avidity Modulation1 , 2003, The Journal of Immunology.
[33] R. Schwartz. T cell anergy. , 2003, Annual review of immunology.
[34] Bernhard Hemmer,et al. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways , 2003, Nature Immunology.
[35] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.
[36] Anjana Rao,et al. Transcriptional Mechanisms Underlying Lymphocyte Tolerance , 2002, Cell.
[37] G. Griffiths,et al. The immunological synapse of CTL contains a secretory domain and membrane bridges. , 2001, Immunity.
[38] J. Berzofsky,et al. An abrupt and concordant initiation of apoptosis: antigen‐dependent death of CD8+ CTL , 2001, European journal of immunology.
[39] T. Yi,et al. Sodium Stibogluconate Is a Potent Inhibitor of Protein Tyrosine Phosphatases and Augments Cytokine Responses in Hemopoietic Cell Lines1 , 2001, The Journal of Immunology.
[40] S. Mok,et al. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. , 2001, Cancer research.
[41] R. Schwartz,et al. Adaptive Tolerance of CD4+ T Cells In Vivo: Multiple Thresholds in Response to a Constant Level of Antigen Presentation , 2001, The Journal of Immunology.
[42] F. Sallusto,et al. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. , 2000, Science.
[43] M. Jenkins,et al. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. , 1999, Journal of immunology.
[44] W. van Eden,et al. Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy. , 1999, Journal of immunology.
[45] Graça Raposo,et al. Antigen-dependent and -independent Ca2+ Responses Triggered in T Cells by Dendritic Cells Compared with B Cells , 1998, The Journal of experimental medicine.
[46] M. Silvy,et al. Differential dose-dependent effects of epidermal growth factor on gene expression in A431 cells: evidence for a signal transduction pathway that can bypass Raf-1 activation. , 1998, Endocrinology.
[47] D. Haverstick,et al. Ca2+ Signaling Modulates Cytolytic T Lymphocyte Effector Functions , 1998, The Journal of experimental medicine.
[48] Dennis R. Merkley,et al. Dynamics of Oxidation of a Fe2+-Bearing Aluminosilicate (Basaltic) Melt , 1996, Science.
[49] K. Siminovitch,et al. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase , 1996, The Journal of experimental medicine.
[50] Antonio Lanzavecchia,et al. T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds , 1996, Science.
[51] D. Plas,et al. Direct Regulation of ZAP-70 by SHP-1 in T Cell Antigen Receptor Signaling , 1996, Science.
[52] A. Lanzavecchia,et al. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy , 1996, The Journal of experimental medicine.
[53] M. Esser,et al. Distinct T cell receptor signaling requirements for perforin- or FasL- mediated cytotoxicity , 1996, The Journal of experimental medicine.
[54] Mary L. Thomas,et al. Biphasic actions of estrogen on colon cancer cell growth: possible mediation by high- and low-affinity estrogen binding sites , 1995, Endocrine.
[55] G. Schönrich,et al. Levels of peripheral T cell tolerance induced by different doses of tolerogen. , 1994, Science.
[56] D. Cantrell,et al. T-cell activation. , 1992, Trends in cell biology.
[57] R. Germain,et al. Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. , 1991, Science.
[58] B. Rocha,et al. Peripheral selection of the T cell repertoire. , 1991, Science.
[59] M. Niks,et al. Quantification of proliferative and suppressive responses of human T lymphocytes following ConA stimulation. , 1990, Journal of immunological methods.
[60] Peter O. Krutzik,et al. Phospho flow cytometry methods for the analysis of kinase signaling in cell lines and primary human blood samples. , 2011, Methods in molecular biology.
[61] Omer Dushek,et al. Mechanisms for T cell receptor triggering , 2011, Nature Reviews Immunology.
[62] J. Schachter,et al. Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy. , 2009, Cytotherapy.
[63] E. Calabrese. Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications. , 2005, Critical reviews in toxicology.
[64] Garry P Nolan,et al. Flow cytometric analysis of kinase signaling cascades. , 2004, Methods in molecular biology.
[65] S. Rosenberg,et al. Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma. , 2000, Journal of immunotherapy.